
Benjamin Botwe, a prominent medicine regulatory and quality assurance expert, has called on Ghana to prioritize the development of local capacity for producing active pharmaceutical ingredients (APIs). Speaking at the 10th anniversary celebration of the School of Pharmacy at the University of Health and Allied Sciences (UHAS), Botwe emphasized that establishing a domestic manufacturing base for these essential components is critical for Ghana to achieve true health sovereignty and secure its medical supply chains.
During his address, Botwe highlighted the significant risks associated with the country's heavy reliance on imported pharmaceutical raw materials. He argued that depending on foreign markets for APIs leaves Ghana vulnerable to global supply chain disruptions and price fluctuations. To mitigate these risks, he urged for a strategic alignment between local manufacturers and the Food and Drugs Authority (FDA) to ensure that domestic production meets international quality standards. This collaboration, he noted, would not only safeguard public health but also bolster the industrial capacity of the nation’s pharmaceutical sector.
Beyond manufacturing, the expert stressed the importance of bridging the gap between academic research and industrial application. He encouraged pharmacy students and faculty to focus on translating scientific findings into practical, market-ready solutions that address local health challenges. By broadening their career aspirations beyond clinical practice to include industrial pharmacy and regulatory science, Botwe believes the next generation of pharmacists can drive innovation and transform Ghana into a regional hub for pharmaceutical excellence.